Summary
- CRISPR Therapeutics is probably the most widely-known company utilizing the original CRISPR-Cas9 gene editing method.
- Prime editing is a newer variation on CRISPR-Cas9 which is safer since it doesn't produce double-strand breaks in DNA.
- During the market turmoil of late last year, many missed the IPO of Prime Medicine. As the name implies, they do prime editing.
- So which company is a better investment? The answer is not black and white and may differ based on your timeframe.
For further details see:
Prime Medicine 'Crispr 3.0' Vs. Crispr Therapeutics